Skip Navigation

This Article
Right arrow Full Text Freely available
Right arrow FREE Full Text (PDF ) Freely available
Right arrow Submit a response
Right arrow Alert me when this article is cited
Right arrow Alert me when eLetters are posted
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in ISI Web of Science
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrow Search for citing articles in:
ISI Web of Science (36)
Right arrowRequest Permissions
Google Scholar
Right arrow Articles by Abramov, Y.
Right arrow Articles by Schenker, J.G.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Abramov, Y.
Right arrow Articles by Schenker, J.G.
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

Human Reproduction, Vol. 14, No. 9, 2181-2183, September 1999
© 1999 European Society of Human Reproduction and Embryology


Debate

Severe OHSS

An `epidemic' of severe OHSS: a price we have to pay?

Y. Abramov, U. Elchalal and J.G. Schenker1

Department of Obstetrics and Gynecology, Hebrew University Hadassah Medical Center, Ein-Kerem, Jerusalem 12000, Israel

Induction of ovulation by gonadotrophins is one of the major developments in the treatment of infertility in the second half of the 20th century. Today, it is the treatment of choice for >40% of infertile women suffering from ovulatory failure. In addition, extracorporeal fertilization techniques, primarily in-vitro fertilization (IVF) and embryo transfer are used for mechanical problems, male factor, and unexplained infertility, and are practised widely in almost every country in the world today.

Successful induction of ovulation should ideally attain as many follicles and oocytes as possible to obtain the maximal number of embryos in a single treatment cycle. This goal is achieved by using regimens employing gonadotrophin-releasing hormone (GnRH) analogues and high dose gonadotrophins. Unfortunately, these regimens are associated with a serious and potentially life-threatening . . . [Full Text of this Article]

Notes

References


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?


This article has been cited by other articles:


Home page
Hum ReprodHome page
H. Mertes and G. Pennings
Oocyte donation for stem cell research
Hum. Reprod., March 1, 2007; 22(3): 629 - 634.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
R. Klemetti, T. Sevon, M. Gissler, and E. Hemminki
Complications of IVF and ovulation induction
Hum. Reprod., December 1, 2005; 20(12): 3293 - 3300.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
G. B. Inge, P. R. Brinsden, and K. T. Elder
Oocyte number per live birth in IVF: were Steptoe and Edwards less wasteful?
Hum. Reprod., March 1, 2005; 20(3): 588 - 592.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
Z.O. Amarin
Bilateral partial oophorectomy in the management of severe ovarian hyperstimulation syndrome: An aggressive, but perhaps life-saving procedure
Hum. Reprod., April 1, 2003; 18(4): 659 - 664.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
A. Raziel, S. Friedler, M. Schachter, D. Strassburger, E. Mordechai, and R. Ron-El
Increased early pregnancy loss in IVF patients with severe ovarian hyperstimulation syndrome
Hum. Reprod., January 1, 2002; 17(1): 107 - 110.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
A. Delvigne and S. Rozenberg
Preventive attitude of physicians to avoid OHSS in IVF patients
Hum. Reprod., December 1, 2001; 16(12): 2491 - 2495.
[Abstract] [Full Text] [PDF]


Home page
CMAJHome page
L. Shanner and J. Nisker
Bioethics for clinicians: 26. Assisted reproductive technologies
Can. Med. Assoc. J., May 1, 2001; 164(11): 1589 - 1594.
[Abstract] [Full Text] [PDF]


Home page
J. Clin. Endocrinol. Metab.Home page
M. Filicori and G. E. Cognigni
Roles and Novel Regimens of Luteinizing Hormone and Follicle-Stimulating Hormone in Ovulation Induction
J. Clin. Endocrinol. Metab., April 1, 2001; 86(4): 1437 - 1441.
[Abstract] [Full Text]


Home page
Hum ReprodHome page
M. L. Uhler, G.R.S. Budinger, S. G.A. Gabram, and M. J. Zinaman
Perforated duodenal ulcer associated with ovarian hyperstimulation syndrome: Case Report
Hum. Reprod., January 1, 2001; 16(1): 174 - 176.
[Abstract] [Full Text] [PDF]


Home page
Hum ReprodHome page
P. E. Egbase
Severe OHSS: How many cases are preventable?
Hum. Reprod., January 1, 2000; 15(1): 8 - 10.
[Full Text] [PDF]


Home page
Hum ReprodHome page
M. A. Graf and R. Fischer
Severe OHSS: An `epidemic' of severe OHSS: a price we have to pay?
Hum. Reprod., December 1, 1999; 14(12): 2930 - 2931.
[Full Text] [PDF]


Home page
Hum ReprodHome page
R.G. Forman
Minimal ovarian stimulation for IVF: appraisal of potential benefits and drawbacks.
Hum. Reprod., November 1, 1999; 14(11): 2681 - 2686.
[Full Text] [PDF]


Home page
Hum ReprodHome page
R.G. Forman
Severe OHSS--an acceptable price?
Hum. Reprod., November 1, 1999; 14(11): 2687 - 2688.
[Full Text] [PDF]


Home page
Hum ReprodHome page
J. Roest
Severe OHSS: An `epidemic' caused by doctors
Hum. Reprod., September 1, 1999; 14(9): 2183 - 2183.
[Full Text] [PDF]